There were 1,867 press releases posted in the last 24 hours and 400,107 in the last 365 days.

High Content Screening (HCS) Market to be Worth US$ 382.9 Mn by 2025: Future Market Insights

High Content Screening (HCS) Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025

VALLEY COTTAGE, NEW YORK, UNITED STATES, July 1, 2015 /EINPresswire.com/ -- Increasing use of high content screening (HCS) in toxicity studies and its effectiveness in drug discovery is anticipated to fuel the global high content screening market during the forecast period 2015-2025. According to a new research report, titled, “High Content Screening (HCS) Market: Global Industry Analysis and Opportunity Assessment 2015-2025”, the global HCS market is anticipated will be worth US$ 382.9 Mn by 2025.

Demand for high content screening systems is robust from the pharmaceutical and biotechnology sector, owing to the effectiveness of HCS systems in drug discovery and toxicity studies. FMI estimates the high content screening installations to expand at a CAGR of 6.6% through 2020 and reach 988 installations by 2025.

High content screening systems are widely used by pharmaceutical and biotechnology companies, government organisations, and independent contract research organisations. According to FMI, increasing applications of high content screening in compound profiling, and target identification and validation will contribute to the growth of the market during the forecast period.

Browse Full "High Content Screening (HCS) Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025" Market Research Report at http://www.futuremarketinsights.com/reports/details/high-content-screening-market

Increasing government support for life sciences research is also anticipated to fuel the high content screening market during the forecast period 2015-2025. Establishment of research-based biotechnology industries in China and India is expected to open new growth opportunities for the stakeholders in the HCS market.

High price can restrain the demand of high-end HCS instruments, especially in the developing world. According to Future Market Insights, developing countries have limited budgets for research and development, and this can curtail the demand during the forecast period.

FMI has segmented the global high content screening (HCS) on the basis of product into cell imaging and analysis equipment, consumables, software, and services.

The cell imaging and analysis segment had a share of nearly 40% in 2015; FMI estimates it to expand at a CAGR of 5.8% through 2020. Among all the sub-segments, software is anticipated to witness the fastest growth through 2020. FMI estimates the software segment to account for 11.2% share of the global HCS market by 2025.

On the basis of application, the high content screening market is segmented into primary and secondary screening, target identification and validation, toxicity studies, compound profiling, and other applications.

Browse Healthcare, Pharmaceuticals and Medical devices Market Insights Research Report: http://www.futuremarketinsights.com/reports/category/healthcare-pharmaceuticals-medical-devices

Primary and secondary screening is the dominant end-use application segment of HCS market. FMI estimates this segment to expand at a CAGR of 6% through 2025 and account for a market share of nearly 36.6%.

Among all the segments, the target identification and validation segment is projected to witness the highest CAGR through 2025. FMI estimates this segment to account for a market share of 19.2% by 2025.

On the basis of key industries, the global HCS market is segmented into pharmaceutical and healthcare, biotechnology, educational institutions, independent CRO, government organisations, and others. Among these pharmaceuticals and healthcare is the dominant segment, accounting for a market share of 35% in 2015. FMI estimates this segment to remain dominant during the forecast period. On the other hand, biotechnology segment is anticipated to register the highest CAGR through 2025.

North America and Western Europe are the most lucrative regions for global high content screening market. North America accounted for a share of 32% of the global HCS market in 2015; FMI estimates the HCS market in North America to expand at a CAGR of 6% during the forecast period.

For more insights on the High Content Screening (HCS) Market, you can request a sample report with TOC at http://www.futuremarketinsights.com/reports/sample/rep-gb-426

The high content screening market in Western Europe is anticipated to expand at a CAGR of 6.2% during the forecast period 2015-2025, and account for a market share of 27.5%.

Key players in the High Content Screening (HCS) market include Olympus Corporation, Dickinson and Company (BD), GE Healthcare, Merck Millipore Corporation, Yokogawa Electric Corporation, Thermo Fisher Scientific Inc., Becton, PerkinElmer Inc., Danaher Corporation (Molecular Devices), Sysmex Corporation and Thorlabs Inc.

Latest Insights:

Gamma Knife Market: http://www.futuremarketinsights.com/reports/details/gamma-knife-market

Fatty Amines Market: http://www.futuremarketinsights.com/reports/details/fatty-amines-market

Smart Camera Market: http://www.futuremarketinsights.com/reports/details/smart-camera-market

About Us

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Our research services cover global as well as regional emerging markets such as GCC, ASEAN, and BRICS. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. FMI’s operating model blends cross-disciplinary research experience to deploy in-depth, insightful and actionable research.

Contact

Christina Johnsan
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
T (UK): + 44 (0) 20 7692 8790
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

Christina Johnsan
Future Market Insights
+1-347-918-3531
email us here